This article has been updated to clarify that a team from Broad Institute and its collaborators originally discovered Cas13a in October 2015.

NEW YORK (GenomeWeb) – A team of University of California, Berkeley researchers led by Jennifer Doudna have published a study describing variants of the Cas13a CRISPR protein that could be used to diagnose disease.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

NPR reports that Turkish high school students will no longer study evolution.

Researchers report they sequenced and identified plant species in an "al fresco" laboratory.

An Australian team searches for genetic alterations linked to depression in hopes of developing personalized treatments, the Sydney Morning Herald reports.

In PNAS this week: host contributors to typhoid fever risk, effects of obesity-related variants near TMEM18, and more.

Sponsored by

This webinar will cover recent advances in the use of CRISPR for generating animal models and cell lines.